It looks as if MalliaBioTech might be often known as Mallia Therapeutics (Germany). The firm was formally based in June 2023.

Update: July 11, 2023

Mallia Therapeutics Secures Seed Funding

Mallia Therapeutics (beforehand MalliaBioTech) lastly has a website (h/t “Ben”). Moreover, the corporate simply introduced that it has raised seed funding. They now plan to boost Series A funding previous to starting medical trials.

The firm is creating a soluble CD83 (sCD83) based mostly  topical remedy of hair loss.

This sCD83 has an immune-modulatory operate and induces hair progress through a twin mode of motion:

  • It induces an anti-inflammatory surroundings across the hair follicles through regulatory T cells (Tregs). These work together with follicular stem cells and activate hair progress.
  • It straight binds to follicular stem cells and induces the formation of new hair follicles. So sCD83 not solely prevents hair loss and accelerates progress, but in addition induces the expansion of latest hair.

Moreover, this remedy will supposedly work for each androgenetic alopecia (AGA) and the much less widespread alopecia areata (AA).

Key quote (barely reworded):

“The company is led by world leading experts in the field of CD83, with more than 60 CD83-related publications and 20 years of relevant experience.”

November 4, 2021

A brand new biotech firm in Germany named MalliaBioTech is engaged on a topical hair loss remedy based mostly on the CD83 molecule. Thanks to “Marcus” and “James” for sending me a number of of the beneath hyperlinks.

CD83 and Hair Loss

On October 27, the Friedrich-Alexander University (FAU) in Germany revealed an vital web page on their website titled:

“FAU project wins funding for remedies against hormone-related hair loss.”

An soluble CD83 based mostly lively ingredient newly developed at FAU results in new hair progress. The FAU researchers from the Department of Immunomodulation and the Department of Dermatology on the University Hospital Erlangen obtained the m4 Award for this undertaking on October 21, 2021.

So far, this CD83 (see gene card) based mostly lively ingredient has not proven any negative effects in pre-clinical research. The video of this work can be found in this article.

Mallia Therapeutics CD83 Hair Growth
CD83 hair progress earlier than and after. Screenshot from Mallia Biotech video.


The analysis crew is led by Dr. Alexander Steinkasserer, who I e-mailed for extra info. His co-researchers embody Dr. Dmytro Royzman and Prof. Dr. Carola Berking. Their new firm is named MalliaBioTech, and it received EUR 500,000 via the m4 Award. It is formally referred to as the m4 Award from the state of Bavaria.

“The new product has the potential to conquer the large unfulfilled market of hair loss.”

In distinction to present hair loss remedies Finasteride and Minoxidil, this topical remedy based mostly on a soluble type of the CD83 molecule:

“Stimulated the formation of new hair follicles and thus induces new hair growth.”

While the present pre-clinical work is in mice and but to enter human medical trials, this analysis represents but another new technique to deal with androgenetic alopecia. We examine no less than 5 such main new hair loss treatment associated discoveries yearly, so reader skepticism is warranted.

When I first heard about CD83 for hair progress, I assumed it will be for alopecia areata. This is because of the frequent use of the word “immune” in tandem with CD83. However, the brand new German analysis clearly signifies that this remedy will work for hormonal hair loss (aka male sample baldness).


Source by [author_name]

Leave a comment

Your email address will not be published. Required fields are marked *